Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)
China
· Delayed Price · Currency is CNY 204.48
-18.52 (-8.30%)
Oct 9, 2024, 2:56 PM CST
Sichuan Biokin Pharmaceutical Co.,Ltd. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Operating Revenue | 5,802 | 560.42 | 701.83 | 794.95 | 1,011 | 1,205 | Upgrade
|
| Other Revenue | 1.73 | 1.46 | 1.45 | 1.78 | 1.66 | 2.12 | Upgrade
|
| Revenue | 5,804 | 561.87 | 703.28 | 796.73 | 1,013 | 1,207 | Upgrade
|
| Revenue Growth (YoY) | 717.90% | -20.11% | -11.73% | -21.33% | -16.07% | 188.63% | Upgrade
|
| Cost of Revenue | 244.46 | 242.26 | 237.7 | 203.39 | 202.02 | 233.95 | Upgrade
|
| Gross Profit | 5,559 | 319.61 | 465.58 | 593.34 | 810.69 | 972.68 | Upgrade
|
| Selling, General & Admin | 349.85 | 367.89 | 403.01 | 467.46 | 636.86 | 830.77 | Upgrade
|
| Research & Development | 957.93 | 746.23 | 375.02 | 278.6 | 195.7 | 181.41 | Upgrade
|
| Other Operating Expenses | 2.17 | -2.27 | 9.79 | 9.17 | 3 | 2.84 | Upgrade
|
| Operating Expenses | 1,303 | 1,105 | 795.41 | 752.86 | 833.55 | 1,011 | Upgrade
|
| Operating Income | 4,256 | -785.6 | -329.83 | -159.52 | -22.85 | -38.67 | Upgrade
|
| Interest Expense | -28.79 | -24.68 | -22.48 | -8.69 | -7.57 | -8.22 | Upgrade
|
| Interest & Investment Income | 87.81 | 5.71 | 0.77 | 3.61 | 4.75 | 3.89 | Upgrade
|
| Currency Exchange Gain (Loss) | 12.08 | -1.11 | -0.05 | -0.14 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -3.5 | -0.84 | -0.56 | -0.35 | 0.02 | 1.38 | Upgrade
|
| EBT Excluding Unusual Items | 4,323 | -806.51 | -352.16 | -165.09 | -25.66 | -41.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | 13.56 | - | - | - | 0.34 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.2 | -0.14 | -0.48 | -0.45 | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.17 | -0.19 | Upgrade
|
| Other Unusual Items | 63.61 | 37.64 | 63.57 | 61.1 | 71.11 | 54.12 | Upgrade
|
| Pretax Income | 4,400 | -769.01 | -289.07 | -104.44 | 45.62 | 12.3 | Upgrade
|
| Income Tax Expense | 186.16 | 11.49 | -6.69 | -4.45 | 7.7 | 4.56 | Upgrade
|
| Earnings From Continuing Operations | 4,214 | -780.5 | -282.38 | -99.99 | 37.92 | 7.74 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -0.02 | -0.01 | Upgrade
|
| Net Income | 4,214 | -780.5 | -282.38 | -99.99 | 37.9 | 7.73 | Upgrade
|
| Net Income to Common | 4,214 | -780.5 | -282.38 | -99.99 | 37.9 | 7.73 | Upgrade
|
| Net Income Growth | - | - | - | - | 390.26% | -55.73% | Upgrade
|
| Shares Outstanding (Basic) | 401 | 400 | 362 | 357 | 345 | 387 | Upgrade
|
| Shares Outstanding (Diluted) | 401 | 400 | 362 | 357 | 345 | 387 | Upgrade
|
| Shares Change (YoY) | 5.11% | 10.56% | 1.38% | 3.64% | -10.86% | 276.33% | Upgrade
|
| EPS (Basic) | 10.52 | -1.95 | -0.78 | -0.28 | 0.11 | 0.02 | Upgrade
|
| EPS (Diluted) | 10.52 | -1.95 | -0.78 | -0.28 | 0.11 | 0.02 | Upgrade
|
| EPS Growth | - | - | - | - | 450.00% | -88.24% | Upgrade
|
| Free Cash Flow | 4,673 | -697.29 | -293.21 | -179.63 | 63.09 | 6.95 | Upgrade
|
| Free Cash Flow Per Share | 11.67 | -1.74 | -0.81 | -0.50 | 0.18 | 0.02 | Upgrade
|
| Gross Margin | 95.79% | 56.88% | 66.20% | 74.47% | 80.05% | 80.61% | Upgrade
|
| Operating Margin | 73.33% | -139.82% | -46.90% | -20.02% | -2.26% | -3.21% | Upgrade
|
| Profit Margin | 72.61% | -138.91% | -40.15% | -12.55% | 3.74% | 0.64% | Upgrade
|
| Free Cash Flow Margin | 80.52% | -124.10% | -41.69% | -22.55% | 6.23% | 0.58% | Upgrade
|
| EBITDA | 4,319 | -727.7 | -272.27 | -109.37 | 26.45 | 8.02 | Upgrade
|
| EBITDA Margin | 74.41% | -129.51% | -38.71% | -13.73% | 2.61% | 0.66% | Upgrade
|
| D&A For EBITDA | 62.82 | 57.9 | 57.56 | 50.16 | 49.31 | 46.69 | Upgrade
|
| EBIT | 4,256 | -785.6 | -329.83 | -159.52 | -22.85 | -38.67 | Upgrade
|
| EBIT Margin | 73.33% | -139.82% | -46.90% | -20.02% | -2.26% | -3.21% | Upgrade
|
| Effective Tax Rate | 4.23% | - | - | - | 16.87% | 37.05% | Upgrade
|
| Revenue as Reported | 5,804 | 561.87 | 703.28 | 796.73 | 1,013 | 1,207 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.